Hypertrophic nonobstructive cardiomyopathy: a precise assessment of hemodynamic characteristics and clinical

Insights

Hypertrophic cardiomyopathy patients show normal systolic function despite impaired relaxation and reduced unit muscle performance. Ventricular hypertrophy may be an adaptive response to maintain cardiac output.

Area of Science:

  • Cardiology
  • Physiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
  • Understanding the pathophysiology of HCM is crucial for patient management.

Purpose of the Study:

  • To precisely assess left ventricular (LV) function in patients with hypertrophic nonobstructive cardiomyopathy (HNOCM).
  • To elucidate the basic pathophysiology of HNOCM by comparing LV function with normal subjects.

Main Methods:

  • Left ventricular function was assessed in 20 HNOCM patients and 22 normal subjects.
  • Key hemodynamic parameters including end-diastolic pressure, end-diastolic stress, afterload, isovolumic indexes (peak positive dP/dt, (dP/dt)/DP40), ejection phase indexes (ejection fraction), end-systolic stress-volume ratio, and LV minute work were measured.

Main Results:

  • HNOCM patients had high end-diastolic pressure but normal end-diastolic stress and reduced afterload.
  • Isovolumic and ejection phase indexes of contractility were normal, but end-systolic stress-volume ratio was significantly reduced.
  • LV relaxation was abnormal (low peak negative dP/dt, prolonged time constant T), and LV stiffness was increased.
  • Unit muscle performance was significantly reduced (49% of normal), despite a normal LV minute work index.

Conclusions:

  • The study suggests impaired unit muscle contraction in HNOCM, leading to inadequate whole ventricle contraction.
  • Ventricular hypertrophy in HNOCM may be an adaptive mechanism to maintain normal systolic function by increasing muscle mass and reducing afterload.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...